医療機器(特定保険医療材料)の保険償還に関する諸問題

書誌事項

タイトル別名
  • Issues around Medical Device Reimbursement
  • イリョウ キキ トクテイ ホケン イリョウ ザイリョウ ノ ホケン ショウカン ニ カンスル ショモンダイ ナイガイ カカクサ ロンギ カラ ヨリ ホウカツテキ ナ ギロン ニ ムケテ
  • From Discussions on Price Differential Between Japan and Overseas to More Comprehensive Discussions
  • 内外価格差論議から,より包括的な議論に向けて

この論文をさがす

抄録

There have been active discussions on the price differential of medical devices between Japan and overseas. However, reduction of the price differential should not be considered as the goal. The mission of device manufacturers is to provide high quality devices in a timely fashion to fit with the quality requirements and health care budget of each country (market), and there are calls for considering a health care policy and system that would allow them to achieve such mission. This article discussed the following:<br><br>(1) Based on data/evidence collected thus far, it was indicated that gaiatsu (foreign government pressure), which was alleged to have allowed medical device manufacturers to gain excess profits, does not exist in actuality.<br>(2) Two underlying causes of cost increases for providing medical devices in Japan were shown: one is the number of hospitals, the other is regulatory hurdles. Also, it was discussed that these two matters have their roots deeply entrenched in the Japanese health care system.<br>(3) By taking an overview of the current device reimbursement rule, it was shown that the current rule has a strong price control mechanism, while at the same time, it has problems such as the possibility that "bad money will drive out good."<br>(4) Three following points should be discussed in the future:<br>I How to avoid the possibility that "bad money will drive out good."<br>II Appropriate balance between regulatory hurdles and reimbursement<br>III Timely introduction of latest technologies and stable supply of medical devices

収録刊行物

  • 医療と社会

    医療と社会 19 (1), 83-96, 2009

    公益財団法人 医療科学研究所

詳細情報 詳細情報について

問題の指摘

ページトップへ